![]() |
市场调查报告书
商品编码
1389738
体外心律调节器市场 - 按技术(单腔、双腔)、按应用(心搏过缓、急性心肌梗塞)、最终用途(医院、心臟护理中心)和预测,2023 - 2032External Pacemaker Market - By Technology (Single-chamber, Dual-chamber), By Application (Bradycardia, Acute Myocardial Infarction), End-use (Hospitals, Cardiac care centers) & Forecast, 2023 - 2032 |
由于心血管疾病发生率的增加以及对增强型治疗设备的需求,全球体外起搏器市场在 2023 年至 2032 年间的CAGR将达到 5%。心臟疾病的加剧推动了对外部起搏器的需求,这对于控制心律异常至关重要。
例如,根据世界心臟联合会(World Heart Federation.org) 发布的《2023 年世界心臟报告》,全球有超过5 亿人与心血管疾病作斗争,导致2021 年约2,050 万人死亡,占全球死亡人数的近三分之一,并且显着上升。估计有 1.21 亿人因 CVD 相关死亡。大约五分之四的心血管疾病死亡发生在低收入和中等收入国家,而心血管健康的进步主要有利于高收入国家。这种明显的健康差距需要紧急关注和纠正。
随着人口老化和生活方式因素导致心臟病,迫切需要先进的便携式起搏器。体外心律调节器市场需求的激增反映了该行业对开发提供有效心臟管理的创新设备的关注,并努力改善患者的治疗结果和生活品质。
整个外部起搏器市场根据应用、最终用户和地区进行分类。
心搏过缓细分市场将在 2023 年至 2032 年间经历重大发展。心搏过缓是一种以心率异常缓慢为特征的疾病,提示需要外部起搏器来调节心律。由于这种情况影响不同年龄的人,市场对便携式、有效起搏器的需求激增。心搏过缓发病率的上升凸显了这些设备在管理心臟异常方面发挥的重要作用,透过创新、高效的体外起搏解决方案推动体外起搏器市场的成长。
从 2023 年到 2032 年,心臟护理中心领域的外部起搏器市场份额将实现显着的CAGR。这些致力于心臟健康的中心依靠外部起搏器及时干预心律不齐。这些设施专注于患者护理和有效治疗,推动了市场对可靠、可携式起搏器的需求。心臟护理中心对这些设备的日益依赖凸显了它们在管理心臟疾病、推动外部起搏器市场份额的进步和创新方面的关键作用。
欧洲体外心律调节器产业从 2023 年到 2032 年将呈现出值得称讚的CAGR。凭藉强调心血管护理的强大医疗保健系统,该地区推动了对先进体外起搏解决方案的需求。由于心血管疾病持续存在,欧洲医疗中心优先考虑可靠的便携式起搏器。市场对创新的关注与欧洲优化心臟护理的承诺一致,反映了欧洲大陆在引导进步和采用尖端外部起搏技术方面的作用。
Global External Pacemaker Market will witness 5% CAGR between 2023 and 2032 due to increased occurrences of cardiovascular diseases and the quest for enhanced treatment devices. Rising heart conditions drive the demand for external pacemakers, crucial in managing cardiac rhythm abnormalities.
For instance, as per the 2023 World Heart Report by the World Heart Federation.org, over 500 million individuals globally grapple with cardiovascular diseases, resulting in approximately 20.5 million deaths in 2021-nearly one-third of all global fatalities and a notable rise from the estimated 121 million CVD-related deaths. Around 4 out of 5 deaths from CVD occur in low- and middle-income nations, while advancements in cardiovascular health predominantly favor high-income countries. This marked health disparity necessitates urgent attention and rectification.
With a growing aging population and lifestyle factors contributing to heart ailments, there's a pressing need for advanced, portable pacemakers. This surge in the external pacemaker market demand reflects the industry's focus on developing innovative devices that offer effective cardiac management, striving to improve patient outcomes and quality of life.
The overall External Pacemaker Market is classified based on application, end-user, and region.
Bradycardia segment will undergo significant development from 2023 to 2032. Bradycardia, a condition marked by an abnormally slow heart rate, prompts the need for external pacemakers to regulate heart rhythm. As this condition affects individuals of varying ages, the market sees a surge in demand for portable, effective pacemakers. The rising incidence of bradycardia underscores the vital role these devices play in managing cardiac abnormalities, driving the external pacemaker market growth from innovative, efficient external pacing solutions.
The external pacemaker market share from the cardiac care centers segment will register a noteworthy CAGR from 2023 to 2032. These centers, dedicated to heart health, rely on external pacemakers for timely intervention in cardiac rhythm irregularities. With a focus on patient care and effective treatment, these facilities drive the market's need for reliable, portable pacemakers. The increasing reliance on these devices within cardiac care centers underscores their critical role in managing cardiac conditions, propelling advancements and innovation within the external pacemaker market share.
Europe external pacemaker industry will showcase a commendable CAGR from 2023 to 2032. With a robust healthcare system emphasizing cardiovascular care, the region drives the need for advanced external pacing solutions. As cardiovascular conditions persist, European healthcare centers prioritize reliable, portable pacemakers. The market's focus on innovation aligns with Europe's commitment to optimizing cardiac care, reflecting the continent's role in steering advancements and adoption of cutting-edge external pacing technologies.